Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM (March 2003). „International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands”. Pharmacol. Rev.55 (1): 21–6. DOI:10.1124/pr.55.1.3. PMID12615952.
Polymeropoulos MH, Torres R, Yanovski JA, Chandrasekharappa SC, Ledbetter DH (July 1995). „The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22”. Genomics28 (1): 123–4. DOI:10.1006/geno.1995.1118. PMID7590738.
Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR (March 2004). „Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors”. Science (journal)303 (5663): 1512–4. DOI:10.1126/science.1092550. PMID15001778.
Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, Liggett SB, Gelfand EW, Rosenwasser LJ, Richter B, Israel E, Wechsler M, Gabriel S, Altshuler D, Lander E, Drazen J, Weiss ST (July 2004). „Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids”. Hum. Mol. Genet.13 (13): 1353–9. DOI:10.1093/hmg/ddh149. PMID15128701.
Kehne JH (June 2007). „The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders”. CNS Neurol Disord Drug Targets6 (3): 163–82. DOI:10.2174/187152707780619344. PMID17511614.
Ising M, Holsboer F (December 2007). „CRH-sub-1 receptor antagonists for the treatment of depression and anxiety”. Exp Clin Psychopharmacol15 (6): 519–28. DOI:10.1037/1064-1297.15.6.519. PMID18179304.
Grammatopoulos, D K; Dai Y, Randeva H S, Levine M A, Karteris E, Easton A J, Hillhouse E W (December 1999). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes”. Mol. Endocrinol. (UNITED STATES) 13 (12): 2189–202. DOI:10.1210/me.13.12.2189. ISSN0888-8809. PMID10598591.
Donaldson, C J; Sutton S W, Perrin M H, Corrigan A Z, Lewis K A, Rivier J E, Vaughan J M, Vale W W (May 1996). „Cloning and characterization of human urocortin”. Endocrinology (UNITED STATES) 137 (5): 2167–70. DOI:10.1210/en.137.5.2167. ISSN0013-7227. PMID8612563.
nih.gov
ncbi.nlm.nih.gov
Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM (March 2003). „International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands”. Pharmacol. Rev.55 (1): 21–6. DOI:10.1124/pr.55.1.3. PMID12615952.
Polymeropoulos MH, Torres R, Yanovski JA, Chandrasekharappa SC, Ledbetter DH (July 1995). „The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22”. Genomics28 (1): 123–4. DOI:10.1006/geno.1995.1118. PMID7590738.
Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR (March 2004). „Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors”. Science (journal)303 (5663): 1512–4. DOI:10.1126/science.1092550. PMID15001778.
Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, Liggett SB, Gelfand EW, Rosenwasser LJ, Richter B, Israel E, Wechsler M, Gabriel S, Altshuler D, Lander E, Drazen J, Weiss ST (July 2004). „Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids”. Hum. Mol. Genet.13 (13): 1353–9. DOI:10.1093/hmg/ddh149. PMID15128701.
Kehne JH (June 2007). „The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders”. CNS Neurol Disord Drug Targets6 (3): 163–82. DOI:10.2174/187152707780619344. PMID17511614.
Ising M, Holsboer F (December 2007). „CRH-sub-1 receptor antagonists for the treatment of depression and anxiety”. Exp Clin Psychopharmacol15 (6): 519–28. DOI:10.1037/1064-1297.15.6.519. PMID18179304.
Grammatopoulos, D K; Dai Y, Randeva H S, Levine M A, Karteris E, Easton A J, Hillhouse E W (December 1999). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes”. Mol. Endocrinol. (UNITED STATES) 13 (12): 2189–202. DOI:10.1210/me.13.12.2189. ISSN0888-8809. PMID10598591.
Donaldson, C J; Sutton S W, Perrin M H, Corrigan A Z, Lewis K A, Rivier J E, Vaughan J M, Vale W W (May 1996). „Cloning and characterization of human urocortin”. Endocrinology (UNITED STATES) 137 (5): 2167–70. DOI:10.1210/en.137.5.2167. ISSN0013-7227. PMID8612563.
worldcat.org
Grammatopoulos, D K; Dai Y, Randeva H S, Levine M A, Karteris E, Easton A J, Hillhouse E W (December 1999). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes”. Mol. Endocrinol. (UNITED STATES) 13 (12): 2189–202. DOI:10.1210/me.13.12.2189. ISSN0888-8809. PMID10598591.
Donaldson, C J; Sutton S W, Perrin M H, Corrigan A Z, Lewis K A, Rivier J E, Vaughan J M, Vale W W (May 1996). „Cloning and characterization of human urocortin”. Endocrinology (UNITED STATES) 137 (5): 2167–70. DOI:10.1210/en.137.5.2167. ISSN0013-7227. PMID8612563.